Cargando…
Targeted inactivation of Salmonella Agona metabolic genes by group II introns and in vivo assessment of pathogenicity and anti-tumour activity in mouse model
The fight against cancer has been a never-ending battle. Limitations of conventional therapies include lack of selectivity, poor penetration and highly toxic to the host. Using genetically modified bacteria as a tumour therapy agent has gained the interest of scientist from the past few decades. Low...
Autores principales: | Gwee, Chin Piaw, Khoo, Chai Hoon, Yeap, Swee Keong, Tan, Geok Chin, Cheah, Yoke Kqueen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339473/ https://www.ncbi.nlm.nih.gov/pubmed/30671294 http://dx.doi.org/10.7717/peerj.5989 |
Ejemplares similares
-
Salmonella Agona Harboring Genomic Island 1-A
por: Doublet, Benoît, et al.
Publicado: (2004) -
Salmonella Agona Outbreak from Contaminated Aniseed, Germany
por: Koch, Judith, et al.
Publicado: (2005) -
Comparative aspects of microRNA expression in canine and human cancers
por: Sahabi, Kabiru, et al.
Publicado: (2018) -
In Vitro Growth Inhibition, Caspase-Dependent Apoptosis, and S and G2/M Phase Arrest in Breast Cancer Cells Induced by Fluorine-Incorporated Gold I Compound, Ph3PAu[SC(OMe)=NC6H4F-3]
por: Yu, Richard Ming Chuan, et al.
Publicado: (2022) -
Neutral Genomic Microevolution of a Recently Emerged Pathogen, Salmonella enterica Serovar Agona
por: Zhou, Zhemin, et al.
Publicado: (2013)